pubrio
SK Plasma

SK Plasma

South Korea · Pharmaceutical Manufacturing

Pharmaceuticals

Biotechnology

Healthcare

Pharmaceutical Manufacturing

Developer of plasma-derived medicine intended to promote human health and protect the environment. The company carries a plasma fractionation business and offers plasma-derived products that are essential medicines to treat diseases that can be directly linked to human life, such as congenital immunodeficiency diseases and hemophilia, enabling doctors to create social value to protect the health of human lives.

Company Insights
Company Overview

2015

Founded

Pharmaceutical Manufacturing

Industry

South Korea

Location

16,175,782

Ranking

36 employees

Size

Similar Companies

Get full access to view complete information

Frequently Asked Questions Regarding SK Plasma

Start your journey today

Start with the platform — or start with a conversation

Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.

pubrio

Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.​